RNS Number : 1177P
Begbies Traynor Group PLC
05 February 2019
 

5 February 2019

 

Begbies Traynor Group plc

 

Director/PDMR Shareholding

 

 

The Company has been advised that Mark Stupples, one of the Company's Non-Executive Directors has acquired 30,727 ordinary shares of 5 pence each in the Company ("Ordinary Shares") at a price of 65.088 pence per share.  As a result of this acquisition, Mark Stupples is deemed to have a beneficial interest of 30,727 Ordinary Shares, representing 0.028% of the total issued share capital of the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Mark Stupples

2.

Reason for the notification

a)

Position / status

Non-Executive Director

b)

Initial notification / amendment

5 February 2019

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Begbies Traynor Group plc

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary 5 pence shares in the Company

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

65.088 pence

30,727

e)

Date of the transaction

5 February 2019

f)

Place of the transaction

London Stock Exchange, AIM

 

For further information:

Begbies Traynor Group plc                                                                      0161 837 1700

John Humphrey


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHUVRRRKBAURAR